Skip to Content
Merck
CN

EMU012321

MISSION® esiRNA

targeting mouse Angpt2

Sign In to View Organizational & Contract Pricing.

Select a Size

Change View

About This Item

NACRES:
NA.51
UNSPSC Code:
41105324
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist


description

Powered by Eupheria Biotech

Quality Level

product line

MISSION®

form

lyophilized powder

esiRNA cDNA target sequence

GAACCAGACAGCAGCACAAACTCGGAAACTGACTGATGTGGAAGCCCAAGTACTAAACCAGACGACAAGACTCGAGCTGCAGCTTCTCCAACATTCTATTTCTACCAACAAATTGGAAAAGCAGATTTTGGATCAGACCAGTGAAATAAACAAGCTACAAAATAAGAACAGCTTCCTAGAACAGAAAGTTCTGGACATGGAGGGCAAGCACAGCGAGCAGCTACAGTCCATGAAGGAGCAGAAGGACGAGCTCCAGGTGCTGGTGTCCAAGCAGAGCTCTGTCATTGACGAGCTGGAGAAGAAGCTGGTGACAGCCACGGTCAACAACTCGCTCCTTCAGAAGCAGCAGCATGACCTAATGGAGACCGTCAACAGCTTGCTGACCATGATGTCATCACCCAACTCCAAGAGCTCGGTTGCTAT

Ensembl | mouse accession no.

NCBI accession no.

shipped in

ambient

storage temp.

−20°C

Gene Information

General description

MISSION® esiRNA are endoribonuclease prepared siRNA. They are a heterogeneous mixture of siRNA that all target the same mRNA sequence. These multiple silencing triggers lead to highly-specific and effective gene silencing.

For additional details as well as to view all available esiRNA options, please visit SigmaAldrich.com/esiRNA.

Legal Information

MISSION is a registered trademark of Merck KGaA, Darmstadt, Germany


Storage Class

10 - Combustible liquids

flash_point_f

Not applicable

flash_point_c

Not applicable

Regulatory Information

新产品

This item has



Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number

It looks like we've run into a problem, but you can still download Certificates of Analysis from our Documents section.

If you need assistance, please contact Customer Support

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library



Don Yuen et al.
Investigative ophthalmology & visual science, 55(5), 3320-3327 (2014-05-02)
Lymphatic research has progressed rapidly in recent years. Lymphatic dysfunction has been found in myriad disorders from cancer metastasis to transplant rejection; however, effective treatment for lymphatic disorders is still limited. This study investigates the role of angiopoietin-2 (Ang-2) in
Changqing Luo et al.
Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology, 34(3), 916-928 (2014-09-10)
To investigate the role of angiopoietin-2 (Ang-2) and IL-18 in the pathogenesis of diabetic nephropathy (DN) and the molecular mechanisms through which alprostadil protects renal function. DN was induced by streptozotocin and intraperitoneal injection of alprostadil was given to diabetic



Global Trade Item Number

SKUGTIN
EMU012321-50UG04061828247455
EMU012321-20UG04061828472741